| Germline mutations in predisposition genes in pediatric cancer J Zhang, MF Walsh, G Wu, MN Edmonson, TA Gruber, J Easton, ... New England Journal of Medicine 373 (24), 2336-2346, 2015 | 1249 | 2015 |
| The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias AK Andersson, J Ma, J Wang, X Chen, AL Gedman, J Dang, J Nakitandwe, ... Nature genetics 47 (4), 330-337, 2015 | 485 | 2015 |
| Diverse and targetable kinase alterations drive histiocytic neoplasms EL Diamond, BH Durham, J Haroche, Z Yao, J Ma, SA Parikh, Z Wang, ... Cancer discovery 6 (2), 154-165, 2016 | 463 | 2016 |
| The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes R Huether, L Dong, X Chen, G Wu, M Parker, L Wei, J Ma, MN Edmonson, ... Nature communications 5 (1), 3630, 2014 | 411 | 2014 |
| The genomic landscape of juvenile myelomonocytic leukemia E Stieglitz, AN Taylor-Weiner, TY Chang, LC Gelston, YD Wang, T Mazor, ... Nature genetics 47 (11), 1326-1333, 2015 | 281 | 2015 |
| An Inv (16)(p13. 3q24. 3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia TA Gruber, AL Gedman, J Zhang, CS Koss, S Marada, HQ Ta, SC Chen, ... Cancer cell 22 (5), 683-697, 2012 | 264 | 2012 |
| The genomic landscape of core-binding factor acute myeloid leukemias ZJ Faber, X Chen, AL Gedman, K Boggs, J Cheng, J Ma, I Radtke, ... Nature genetics 48 (12), 1551-1556, 2016 | 259 | 2016 |
| Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study CH Pui, D Pei, E Coustan-Smith, S Jeha, C Cheng, WP Bowman, ... The lancet oncology 16 (4), 465-474, 2015 | 232 | 2015 |
| Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude Total Therapy Study 16 S Jeha, D Pei, J Choi, C Cheng, JT Sandlund, E Coustan-Smith, ... Journal of Clinical Oncology 37 (35), 3377-3391, 2019 | 208 | 2019 |
| Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes JDE De Rooij, C Branstetter, J Ma, Y Li, MP Walsh, J Cheng, A Obulkasim, ... Nature genetics 49 (3), 451-456, 2017 | 194 | 2017 |
| Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome M Rusch, J Nakitandwe, S Shurtleff, S Newman, Z Zhang, MN Edmonson, ... Nature communications 9 (1), 3962, 2018 | 177 | 2018 |
| Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with response-adapted therapy CH Pui, D Pei, SC Raimondi, E Coustan-Smith, S Jeha, C Cheng, ... Leukemia 31 (2), 333-339, 2017 | 174 | 2017 |
| Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia S Klossowski, H Miao, K Kempinska, T Wu, T Purohit, EG Kim, ... The Journal of clinical investigation 130 (2), 981-997, 2020 | 173 | 2020 |
| A revised definition for cure of childhood acute lymphoblastic leukemia CH Pui, D Pei, D Campana, C Cheng, JT Sandlund, WP Bowman, ... Leukemia 28 (12), 2336-2343, 2014 | 164 | 2014 |
| Pre–B cell receptor–mediated cell cycle arrest in Philadelphia chromosome–positive acute lymphoblastic leukemia requires IKAROS function D Trageser, I Iacobucci, R Nahar, C Duy, G von Levetzow, L Klemm, ... Journal of Experimental Medicine 206 (8), 1739-1753, 2009 | 151 | 2009 |
| The biology of pediatric acute megakaryoblastic leukemia TA Gruber, JR Downing Blood, The Journal of the American Society of Hematology 126 (8), 943-949, 2015 | 147 | 2015 |
| Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease–directed therapy S Jeha, J Choi, KG Roberts, D Pei, E Coustan-Smith, H Inaba, JE Rubnitz, ... Blood cancer discovery 2 (4), 326-337, 2021 | 95 | 2021 |
| St. Jude Children’s Research Hospital–Washington University pediatric cancer genome project. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic … AK Andersson, J Ma, J Wang, X Chen, AL Gedman, J Dang, J Nakitandwe, ... Nat Genet 47 (4), 330-337, 2015 | 80 | 2015 |
| An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia A Lasry, B Nadorp, M Fornerod, D Nicolet, H Wu, CJ Walker, Z Sun, ... Nature cancer 4 (1), 27-42, 2023 | 68 | 2023 |
| A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia AH Elsayed, R Rafiee, X Cao, S Raimondi, JR Downing, R Ribeiro, Y Fan, ... Leukemia 34 (3), 735-745, 2020 | 68 | 2020 |
